5-membered annelated heterocyclic pyrimidines as kinase inhibitors

Details for Australian Patent Application No. 2006205851 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Lacrampe, Jean Fernand Armand; Ligny, Yannick Aime Eddy; Freyne, Eddy Jean Edgard; Ten Holte, Peter; Lavrijssen, Tom; Lardeau, Delphine Yvonne Raymonde; Perera, Timothy Pietro Suren

Agent Shelston IP

Pub. Number AU-A-2006205851

PCT Pub. Number WO2006/074985

Priority 60/644,767 18.01.05 US; 05100222.8 14.01.05 EP

Filing date 9 January 2006

Wipo publication date 20 July 2006

International Classifications

C07D 473/32 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/074985 Priority application(s): WO2006/074985

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006205852-Improved PRRS vaccines

2006205850-Pyrazolopyrimidines as cell cycle kinase inhibitors